RB1 mutations and second primary malignancies after hereditary retinoblastoma

Familial Cancer

Volumn 11, Issue 2, 2012, Pages 225-233

  Dommering, Charlotte J ^a   Marees, Tamara ^a,b   Van Der Hout, Annemarie H ^c   Imhof, Saskia M ^a,d   Meijers Heijboer, Hanne ^a   Ringens, Peter J ^a   Van Leeuwen, Flora E ^a,e   Moll, Annette C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Genotype phenotype correlation; Germline mutation; RB1 gene; Retinoblastoma; Second primary malignancies

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CHILD; CLINICAL ARTICLE; ENUCLEATION; FAMILIAL CANCER; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENOTYPE; GERM LINE; HETEROZYGOTE; HUMAN; INFANT; LARGE REARRANGEMENT; MALE; MISSENSE MUTATION; NONSENSE MUTATION; PENETRANCE; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; RB1 GENE; RETINOBLASTOMA; SCHOOL CHILD; SECOND CANCER; SPLICE MUTATION;

ADOLESCENT; ADULT; AGED; CHILD; CODON, NONSENSE; COHORT STUDIES; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GERM-LINE MUTATION; HUMANS; INFANT; MIDDLE AGED; MODELS, GENETIC; MUTATION; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; RETROSPECTIVE STUDIES; SURVIVORS; YOUNG ADULT;

EID: 84864719217     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-011-9505-3     Document Type: Article

References (31)

1. Mahoney MC, Burnett WS, Majerovics A, Tanenbaum H (1990) The epidemiology of ophthalmic malignancies in New York State. Ophthalmology 97:1143-1147
2. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646
3. Knudson AG Jr (1971) Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823
4. Burkhart DL, Sage J (2008) Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8:671-682
5. Leiderman YI, Kiss S, Mukai S (2007) Molecular genetics of RB1-The retinoblastoma gene. Semin Ophthalmol 22:247-254
6. Moll AC, Imhof SM, Bouter LM, Kuik DJ, den OW, Bezemer PD, Koten JW, Tan KE (1996) Second primary tumors in patients with hereditary retinoblastoma: A register-based follow-up study, 1945-1994. Int J Cancer 67:515-519
7. Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J (2004) Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 96:357-363
8. Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni JF Jr (2005) Risk of new cancers after radiotherapy in long-Term Survivors of retinoblastoma: An extended follow-up. J Clin Oncol 23:2272-2279
9. Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE (2008) Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up. J Natl Cancer Inst 100:1771-1779
10. Woo KI, Harbour JW (2010) Review of 676 second primary tumors in patients with retinoblastoma: Association between age at onset and tumor type. Arch Ophthalmol 128:865-870
11. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD Jr (1993) Mortality from second tumors among long-Term survivors of retinoblastoma. J Natl Cancer Inst 85:1121-1128
12. Yu CL, Tucker MA, Abramson DH, Furukawa K, Seddon JM, Stovall M, Fraumeni JF Jr, Kleinerman RA (2009) Cause-specific mortality in long-Term survivors of retinoblastoma. J Natl Cancer Inst 101:581-591
13. Marees T, van Leeuwen FE, de Boer MR, Imhof SM, Ringens PJ, Moll AC (2009) Cancer mortality in long-Term survivors of retinoblastoma. Eur J Cancer 45:3245-3253
14. Mancini D, Singh S, Ainsworth P, Rodenhiser D (1997) Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1). Am J Hum Genet 61:80-87
15. Lohmann DR (1999) RB1 gene mutations in retinoblastoma. Hum Mutat 14:283-288
16. Valverde JR, Alonso J, Palacios I, Pestana A (2005) RB1 gene mutation up-date, a meta-Analysis based on 932 reported mutations available in a searchable database. BMC Genet 6:53
17. Duncan BK, Miller JH (1980) Mutagenic deamination of cytosine residues in DNA. Nature 287:560-561
18. Harbour JW (2001) Molecular basis of low-penetrance retinoblastoma. Arch Ophthalmol 119:1699-1704
19. Lohmann DR, Gallie BL (2004) Retinoblastoma: Revisiting the model prototype of inherited cancer. Am J Med Genet C Semin Med Genet 129:23-28
20. Albrecht P, Ansperger-Rescher B, Schuler A, Zeschnigk M, Gallie B, Lohmann DR (2005) Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression. Hum Mutat 26:437-445
21. Taylor M, Dehainault C, Desjardins L, Doz F, Levy C, Sastre X, Couturier J, Stoppa-Lyonnet D, Houdayer C, Gauthier-Villars M (2007) Genotype-phenotype correlations in hereditary familial retinoblastoma. Hum Mutat 28:284-293
22. Lohmann DR, Brandt B, Hopping W, Passarge E, Horsthemke B (1994) Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum Genet 94:349-354
23. Scheffer H, van der Vlies P, Burton M, Verlind E, Moll AC, Imhof SM, Buys CH (2000) Two novel germline mutations of the retinoblastoma gene (RB1) that show incomplete penetrance, one splice site and one missense. J Med Genet 37:E6
24. Chang YF, Imam JS, Wilkinson MF (2007) The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem 76:51-74
25. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE (2004) Nonsense-mediated decay approaches the clinic. Nat Genet 36:801-808
26. Bhuvanagiri M, Schlitter AM, Hentze MW, Kulozik AE (2010) NMD: RNA biology meets human genetic medicine. Biochem J 430:365-377
27. Resta N, Susca FC, Di Giacomo MC, Stella A, Bukvic N, Bagnulo R, Simone C, Guanti G (2006) A homozygous frameshift mutation in the ESCO2 gene: Evidence of intertissue and interindividual variation in Nmd efficiency. J Cell Physiol 209:67-73
28. Linde L, Boelz S, Neu-Yilik G, Kulozik AE, Kerem B (2007) The efficiency of nonsense-mediated mRNA decay is an inherent character and varies among different cells. Eur J Hum Genet 15:1156-1162
29. Karam R, Carvalho J, Bruno I, Graziadio C, Senz J, Huntsman D, Carneiro F, Seruca R, Wilkinson MF, Oliveira C (2008) The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers. Oncogene 27:4255-4260
30. Zhang K, Nowak I, Rushlow D, Gallie BL, Lohmann DR (2008) Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression. Hum Mutat 29:475-484
31. Lohmann DR, Brandt B, Hopping W, Passarge E, Horsthemke B (1996) The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 58:940-949